FACS analysis of fresh BC tissues reveals that TIM3 is expressed only on a small fraction of CD4+ and CD8+ TIL (Figure 6B; Table S5 in Supplementary Material) with CD19+ B cell TIL TIM3-negative (Figure S6A in Supplementary Material). Here, HAVCR2 is linked to breast cancer.